Catania, Angela <br/><br/>
Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells.  [electronic resource] 

 -  Breast cancer research and treatment  Aug 2013 
 - 55-65 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-013-2667-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Anticarcinogenic Agents--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Biological Availability<br/>Biological Products--administration & dosage<br/>Breast Neoplasms--metabolism<br/>Carcinoma, Ductal, Breast--metabolism<br/>Cell Division--drug effects<br/>Cell Line, Tumor--drug effects<br/>Cholesterol<br/>Chromatography, High Pressure Liquid<br/>Curcumin--administration & dosage<br/>Drug Compounding<br/>Drug Screening Assays, Antitumor<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Genes, erbB-2<br/>Humans<br/>Immunoconjugates--administration & dosage<br/>Liposomes<br/>Neoplasm Proteins--biosynthesis<br/>Particle Size<br/>Phosphatidylcholines<br/>Phosphatidylethanolamines<br/>Receptor, ErbB-2--biosynthesis<br/>Resveratrol<br/>Stilbenes--administration & dosage<br/>Trastuzumab